Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 89Thoracic 67Breast 28Gynecologic 26Head & Neck 17Lymphoid 10Sarcoma 8Other hematologic neoplasm 8Genitourinary 7CNS 7Other solid neoplasm 6Tumor-Agnostic 4Endocrine 3NET 2Dermatologic 2

Conditions

Carcinoma, Neuroendocrine 2Sarcoma 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Advanced Pancreatic Neuroendocrine Tumor 1Adrenocortical Carcinoma 1

Interventions

lutetium Lu 177 dotatate 16Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 9Specimen Handling 8Everolimus 8pembrolizumab 7cabozantinib 6Cisplatin 6fluorodopa F 18 5Etoposide 5trametinib 4surufatinib 4lanreotide 4dabrafenib 4cemiplimab 4X-Rays 4Temozolomide 4Nivolumab 4Lutetium-177 4Lutetium 4Fluorodeoxyglucose F18 4Carboplatin 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3lenvatinib 3copper dotatate CU-64 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Surveys and Questionnaires 3Somatostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Drug Therapy × Endocrine × Clear all
NCT06333314 2025-12-02

Pan-MSI-ACSE

UNICANCER

Phase 2 Recruiting
120 enrolled
EndocrineSarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Recruiting
60 enrolled
EndocrineNET

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06246630 2024-05-16

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Ruijin Hospital

Phase NA Recruiting
20 enrolled
EndocrineGastrointestinalNET

Advanced Pancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡